Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer. - Wikidata - awgldk - TriplyDB

Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer.

Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer.

http://www.wikidata.org/entity/Q37715020

about

Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.The influence of thyroid dysfunction on bone metabolism.Low BMI and low TSH value as risk factors related to lower bone mineral density in postmenospausal women under levothyroxine therapy for differentiated thyroid carcinoma.Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients on Suppressive Levothyroxine Therapy for Differentiated Thyroid Carcinoma.Role of Thyroid Hormones in Skeletal Development and Bone Maintenance.Evaluation of Bone Density, Serum Total and Ionized Calcium, Alkaline Phosphatase and 25-hydroxy Vitamin D in Papillary Thyroid Carcinoma, and their Relationship with TSH Suppression by Levothyroxine Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery.Risk of osteoporosis in thyroid cancer patients using levothyroxine: a population-based study.Effects of electromagnetic fields on bone loss in hyperthyroidism rat model.Effects of thyrotropin suppression on lumbar bone mineral density in postmenopausal women with differentiated thyroid carcinoma

P2860

Q33841822-0A1EB810-5448-4997-9957-F95F7D0B540A Q35041375-D8FEBC35-321C-4498-AF30-A63457B7F82D Q35760578-11FF3ED6-E09E-48FC-A51F-55460A7EA8C1 Q36065371-7758B8E7-30C0-4B26-9FDB-2D42424F5523 Q36773018-58E97FD8-5F0B-41E1-B166-1D26FBDE6E76 Q38614900-17A35E77-B77D-4B45-A36C-78D9E10DF1D9 Q38737740-AA7298CD-D6A2-4BE8-B479-6631F7DC7422 Q47700549-ABED26AE-CFCC-4C2F-B80A-AD6002589C81 Q51079672-4AEA575E-14B0-4E3C-93AF-9D4178345C72 Q57817289-642D5BBD-9B87-4E41-BCC3-867CF9EE5B69

P2860

Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer.

http://www.wikidata.org/entity/Q37715020

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bone mineral density and bone ...... differentiated thyroid cancer.

@en

Bone mineral density and bone ...... differentiated thyroid cancer.

@nl

type

label

Bone mineral density and bone ...... differentiated thyroid cancer.

@en

Bone mineral density and bone ...... differentiated thyroid cancer.

@nl

prefLabel

Bone mineral density and bone ...... differentiated thyroid cancer.

@en

Bone mineral density and bone ...... differentiated thyroid cancer.

@nl

P1433

Q37715020-6B93A063-B12C-4AF4-8B52-C50987784B23

P1476

Q37715020-5A912EC9-EA2B-48C6-B95A-51E477ED0D40

P2093

Q37715020-22ED52DD-0E28-43D3-A12E-50912EDE4A33

Q37715020-3B47A496-ADE3-4B5A-AF09-2F45387CDA11

Q37715020-57A5DC83-BAAA-4D06-95DC-261D85EA8251

Q37715020-752ED842-0BDE-4EB2-82B7-460A4F44C982

Q37715020-AC2F7AE4-D500-4481-8353-F7A4D23F00A1

Q37715020-E7AD6F24-689F-4288-A273-460D4733BB0A

Q37715020-F4BB00C7-AA4E-4FF5-ABFC-263456CFFEC6

Q37715020-F6639446-4E3C-4679-BAF2-F87FA5A0F491

P2860

Q37715020-0A3F63E9-7F09-4551-AF33-0165F437FD23

Q37715020-20CC38CE-5817-424C-B535-E5D5CDD5907F

Q37715020-297B794E-595F-4B11-B0CD-C5CC8F8FB6E3

Q37715020-3281005D-CB7A-45B1-BD35-5A28A8A6D81C

Q37715020-36F0BFCE-2B84-406F-8213-7F5A5517A6DF

Q37715020-510E69E8-45FD-4081-B0ED-4B000217CF68

Q37715020-5504136B-86BE-495B-8F3E-E67958220B0A

Q37715020-8874858A-F42D-4BAE-83BA-0B27FC9E6F82

Q37715020-93A4BB9D-7373-4D2B-9DE8-815A5F0506FB

Q37715020-94A77C05-B311-4684-85F1-6987C710571D

P304

Q37715020-C25888BF-846E-4161-BBB8-4705F29F638F

P31

Q37715020-4D359908-A915-4C75-9370-96D40FF7F0F7

P356

Q37715020-5D348FC0-88D0-4E94-818C-D52F2194EBFF

P433

Q37715020-9CD26908-C247-4D82-9633-9C510DDA1116

P478

Q37715020-D5AF9B67-68FE-46BF-953D-6665D875C0E9

P50

Q37715020-1A0499C7-1F7E-4E79-BB29-514A907394D7

Q37715020-8B2A89BE-777F-4EF2-9439-A24797820555

P577

Q37715020-9A233991-098C-4A5E-B546-F683D43F3610

P5875

Q37715020-7AF52A6B-AE77-417E-8CBB-3E713AB0342F

P698

Q37715020-5406BEF5-EAE2-466D-A389-42AD1E8D4554

P932

Q37715020-7E4120BA-216E-4F7E-B643-B469B31D288A

P356

ASTR.2014.86.2.55

P1433

Annals of surgical treatment and research

P1476

Bone mineral density and bone ...... differentiated thyroid cancer.

@en

P2093

An Na Ko

http://www.w3.org/2001/XMLSchema#string

Jae Hyun Park

http://www.w3.org/2001/XMLSchema#string

Jang Yel Shin

http://www.w3.org/2001/XMLSchema#string

Jung Soo Lim

http://www.w3.org/2001/XMLSchema#string

Mi Young Lee

http://www.w3.org/2001/XMLSchema#string

Seong Joon Kang

http://www.w3.org/2001/XMLSchema#string

Yong Gwan Jee

http://www.w3.org/2001/XMLSchema#string

Yong Jea Han

http://www.w3.org/2001/XMLSchema#string

P2860

The skeletal consequences of thyrotoxicosis

Effects of thyroid hormones on bone and mineral metabolism.

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.

Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature.

Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis.

A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism.

Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease.

Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.

Weak evidence of thyrotropin receptors in primary cultures of human osteoblast-like cells.

P304

55-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4174/ASTR.2014.86.2.55

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Choon Hee Chung

P577

2014-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261840967

http://www.w3.org/2001/XMLSchema#string

P698

24761409

http://www.w3.org/2001/XMLSchema#string

P932

3994597

http://www.w3.org/2001/XMLSchema#string